Key result
Cardiac MyBP-C type I predominates in developing heart myofibrils, while type II marks skeletal muscle.
Why the study?
Two variants of cardiac MyBP-C (phosphorylatable type I and non-phosphorylatable type II) had been detected in chicken striated muscle, motivating an examination of their specific expression and localization during cardiac and skeletal muscle development.
Answers are grounded in this paper and cite their sources.
Type I predominates in cardiac myofibrils while type II marks embryonic skeletal muscle; leaves open isoform-specific roles in human sarcomere disorders.
Myosin-binding protein-C (MyBP-C), also known as C-protein, is a major myosin-binding protein characteristic of striated muscle, and plays a critical role in myofibril organization, especially in registration of thick filaments in the sarcomeres during myofibrillogenesis. We previously demonstrated that cardiac-type MyBP-C is involved early in the process of myofibrillogenesis in both cardiac and skeletal muscle during chicken muscle development. Two variants (type I and type II) have been detected in chicken cardiac MyBP-C; they differ only in the presence or absence of a sequence of 15 amino acid residues (termed P-seq) that includes a phosphorylation site for cyclic AMP-dependent kinase in the cardiac MyBP-C motif ( Yasuda et al, 1995 ). Therefore, types I and II are regarded as phosphorylatable and non-phosphorylatable isoforms, respectively. In this study, an antibody specific for P-seq was prepared. With this and other monoclonal antibodies to cardiac MyBP-C (C-315), expression and localization of the two MyBP-C isoforms in developing chicken cardiac and skeletal muscle were examined by immunocytochemistry and immunoblotting. The results showed that type I is predominantly expressed in the heart and is localized in myofibrils of both atrial and ventricular muscles through development. In contrast, type II is mainly expressed in embryonic skeletal muscle, although type I is faintly expressed in cultured skeletal muscle. These observations were confirmed by RT-PCR.
No takes yet. Share an insight, caveat, or question.
Saruta et al. (2010) studied Developing chicken cardiac and skeletal muscle myofibrillogenesis. Cardiac MyBP-C type I and type II isoform expression (detected via P-seq and C-315 antibodies) vs. Developing chicken skeletal muscle vs cardiac muscle was evaluated on Expression and localization of type I and type II cardiac MyBP-C isoforms. Cardiac MyBP-C type I (with the 15-amino acid P-seq) is predominantly expressed in developing chicken heart myofibrils, whereas type II is mainly expressed in embryonic skeletal muscle.
Synapse has enriched 10 related papers. Consider them for comparative context: